Published in:
01-04-2020 | Multiple Myeloma | Multiple Myeloma (P Kapoor, Section Editor)
Supportive Care in Multiple Myeloma
Published in: Current Hematologic Malignancy Reports | Issue 2/2020
Login to get accessAbstract
Purpose of Review
As novel therapies are expanding the life expectancy of patients with multiple myeloma, appropriate supportive care has become critical in the management of these patients. This review aims to outline the key principles of supportive care of patients with myeloma, including management of bone disease, renal disease, anemia, peripheral neuropathy, infections, and venous thromboembolism.
Recent Findings
The results from large randomized, controlled trials on the use of high-cutoff hemodialysis in the removal of free light chains in renal disease and the use of levofloxacin in the prevention of infections have recently been published. These results, along with updated guidelines from professional societies on the use of bisphosphonates and erythropoietin stimulating agents, have provided guidance on more effective management strategies for myeloma patients.
Summary
Integration of these updated guidelines and supportive care strategies into clinical practice will help to ensure quality of life for patients with myeloma.